The next wave of growth will belong not to the fastest manufacturers but…
As India moves into 2026, industry experts state that the next phase of growth…
Interviews
Rx-to-OTC is not a channel shift—it’s a complete business model shift
By 2030, what will truly differentiate winning OTC players in India from the rest?
By 2030, the biggest differentiator for…
Good pharma-focused developers are now co-designing with GMP/WHO/USFDA consultants from day zero
How have pharma companies changed the way they plan and choose real estate after the pandemic? What matters most to them now,…
Local focus to strengthen Indian pharmaceutical manufacturers
Why is localising format part production an important step for Indian pharmaceutical companies and Romaco?
Sanjeev Nimkar: It…
